Filter posts

2009 - A Big Year for the BTK

The Amex Biotech Index, the BTK, outpaced its peer, the Nasdaq Biotech Index, by 29% …

Small Biotechs Spending Less

The median and mean operational cash spending for small public US biotechs (less than 250 …

1 in 4 Biotechs Above 100% - Waterfall Chart YTD

Year to date,  27% of biotech stocks have doubled in price. 65% are in positive …

The Rise and Fall of Undervaluation

If “price to cash” is a usable metric for fair value of a risky biotech …